Malignant mesothelioma among US Medicare beneficiaries: incidence, prevalence and therapy, 2016-2019.

Mesothelioma was a prevalent disease among FFS Medicare beneficiaries during 2016-2019, and a limited proportion of beneficiaries received all three therapy modalities. Medicare data build on findings from cancer registry data to enhance our understanding of the mesothelioma burden and therapy patterns.